Biosearch Licenses Stellaris RNA FISH-based Technology from UMDNJ | GenomeWeb

NEW YORK (GenomeWeb News) – Biosearch Technologies today said that it has acquired the exclusive worldwide rights to continuing Stellaris RNA FISH-based inventions from the University of Medicine and Dentistry of New Jersey.

The Stellaris technology has been extended to directly and quantitatively detect chromosomal diseases resulting from translocations and aberrant splice junctions and SNPs, as well as single-molecule detection of mRNA, long non-coding RNA, and viral RNAs, Biosearch said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.